Delatestryl 300 AMPULES - Canada Peptides

In Germany, Schering AG developed Testoviron Depot, a testosterone enanthate preparation that entered the European market in the 1950s. Unlike shorter esters, it maintained therapeutic blood levels with fewer injections, gaining fast acceptance in hormone replacement. It became one of the most enduring testosterone brands in Europe, continuing even after Schering’s acquisition by Bayer. The product’s longevity reflects its clinical reliability, and it remained a mainstay in European endocrinology for more than five decades, influencing later testosterone drug formulations in global medicine.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Delatestryl 300 AMPULES by Canada Peptides, consult with your doctor or healthcare professional.